SRTS — Sensus Healthcare Share Price
0.000.00%
Last trade - 00:00- $50.70m
- $28.62m
- $27.48m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.05 | ||
| Price to Tang. Book | 1.05 | ||
| Price to Free Cashflow | 152.72 | ||
| Price to Sales | 1.84 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.33% | ||
| Return on Equity | -14.85% | ||
| Operating Margin | -37.5% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 27.04 | 44.53 | 24.41 | 41.81 | 27.48 | 27.48 | 36.89 | 23.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +207.5 | -96.48 | +1356.31 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sensus Healthcare, Inc. is a medical device company. The Company is engaged in the development and delivery of non-invasive treatments for non-melanoma skin cancer (NMSC) and post-surgical keloid scar prevention. The Company uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is incorporated into a portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT technology is used to effectively and safely treat oncological and non-oncological skin conditions. The SRT-100 is a photon x-ray low-energy SRT system that provides patients with an alternative to surgery for treating NMSC, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with an SRT-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and comprehensive dosimetry parameters.
Directors
- Joseph Sardano CHM (69)
- Michael Sardano PRE (33)
- Javier Rampolla CFO (49)
- Nicolas Soro COO (36)
- Yonatan Vainer CTO (34)
- Megan Cornish DRC (36)
- Anthony Petrelli NED (68)
- John Heinrich NID (74)
- William McCall NID (74)
- Samuel O'Rear NID (73)
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- May 7th, 2010
- Public Since
- June 3rd, 2016
- No. of Shareholders
- 16
- No. of Employees
- 60
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 16,462,059
- Address
- 851 Broken Sound Pkwy NW Ste 215, BOCA RATON, 33487-3635
- Web
- https://sensushealthcare.com/
- Phone
- +1 3023513367
- Auditors
- Carr, Riggs & Ingram, LLC
Upcoming Events for SRTS
Sensus Healthcare Inc Annual Shareholders Meeting
Q2 2026 Sensus Healthcare Inc Earnings Release
Similar to SRTS
20/20 Biolabs
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Sensus Healthcare share price?
As of Today at 23:10 UTC, shares in Sensus Healthcare are trading at $3.08. This share price information is delayed by 15 minutes.
How has the Sensus Healthcare share price performed this year?
Shares in Sensus Healthcare last closed at $3.08 and the price had moved by -31.1% over the past 365 days. In terms of relative price strength the Sensus Healthcare share price has underperformed the S&P500 Index by -47.29% over the past year.
What are the analyst and broker recommendations for Sensus Healthcare?
The overall consensus recommendation for Sensus Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sensus Healthcare dividend yield?
Sensus Healthcare does not currently pay a dividend.
Does Sensus Healthcare pay a dividend?
Sensus Healthcare does not currently pay a dividend.
When does Sensus Healthcare next pay dividends?
Sensus Healthcare does not currently pay a dividend.
How do I buy Sensus Healthcare shares?
To buy shares in Sensus Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sensus Healthcare?
As of the previous close price of $3.08, shares in Sensus Healthcare had a market capitalisation of $50.70m.
Where are Sensus Healthcare shares listed?
Here are the trading details for Sensus Healthcare:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SRTS
What kind of share is Sensus Healthcare?
Based on an overall assessment of its quality, value and momentum Sensus Healthcare is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sensus Healthcare share price forecast for 2026?
The analyst consensus target price for shares in Sensus Healthcare is $6.88. That is 123.38% above the last closing price of $3.08.
Analysts covering Sensus Healthcare currently have a consensus Earnings Per Share (EPS) forecast of -$0.26 for the next financial year.
Find out moreWhat is the trend in the Sensus Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sensus Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -32.28%.
As of the last closing price of $3.08, shares in Sensus Healthcare were trading -22.87% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sensus Healthcare PE Ratio?
The Sensus Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $3.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sensus Healthcare?
Sensus Healthcare's management team is headed by:
- Joseph Sardano - CHM
- Michael Sardano - PRE
- Javier Rampolla - CFO
- Nicolas Soro - COO
- Yonatan Vainer - CTO
- Megan Cornish - DRC
- Anthony Petrelli - NED
- John Heinrich - NID
- William McCall - NID
- Samuel O'Rear - NID